Follow
Mikhail Blagosklonny
Mikhail Blagosklonny
Professor of Oncology, RPCI and Editor-in-Chief, Oncotarget
Verified email at oncotarget.com
Title
Cited by
Cited by
Year
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
52332018
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G Kroemer, L Galluzzi, P Vandenabeele, J Abrams, ES Alnemri, ...
Cell death & differentiation 16 (1), 3-11, 2009
39712009
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L Galluzzi, I Vitale, JM Abrams, ES Alnemri, EH Baehrecke, ...
Cell Death & Differentiation 19 (1), 107-120, 2012
31162012
Stabilization of wild-type p53 by hypoxia-inducible factor 1α
WG An, M Kanekal, MC Simon, E Maltepe, MV Blagosklonny, LM Neckers
Nature 392 (6674), 405-408, 1998
11511998
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L Galluzzi, BS Pedro, I Vitale, SA Aaronson, JM Abrams, D Adam, ...
Cell Death & Differentiation 22 (1), 58-73, 2015
11372015
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death
G Kroemer, W El-Deiry, P Golstein, ME Peter, D Vaux, P Vandenabeele, ...
Cell death and differentiation 12, 1463-1467, 2005
11112005
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ...
Cell Death & Differentiation 16 (8), 1093-1107, 2009
8222009
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms
V Sandor, S Bakke, RW Robey, MH Kang, MV Blagosklonny, J Bender, ...
Clinical Cancer Research 8 (3), 718-728, 2002
6852002
The restriction point of the cell cycle
MV Blagosklonny, AB Pardee
Cell cycle 1 (2), 102-109, 2002
6212002
Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras Association (∗)
TW Schulte, MV Blagosklonny, C Ingui, L Neckers
Journal of Biological Chemistry 270 (41), 24585-24588, 1995
5711995
Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway
MV Blagosklonny, T Schulte, P Nguyen, J Trepel, LM Neckers
Cancer research 56 (8), 1851-1854, 1996
5501996
Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death
MV Blagosklonny, P Giannakakou, WS El-Deiry, DGI Kingston, PI Higgs, ...
Cancer research 57 (1), 130-135, 1997
5221997
Molecular effects of paclitaxel: myths and reality (a critical review)
MV Blagosklonny, T Fojo
International journal of cancer 83 (2), 151-156, 1999
4901999
Aging: Ros or tor
MV Blagosklonny
Cell cycle 7 (21), 3344-3354, 2008
4752008
p53 is associated with cellular microtubules and is transported to the nucleus by dynein
P Giannakakou, DL Sackett, Y Ward, KR Webster, MV Blagosklonny, ...
Nature cell biology 2 (10), 709-717, 2000
4622000
Rapamycin decelerates cellular senescence
ZN Demidenko, SG Zubova, EI Bukreeva, VA Pospelov, TV Pospelova, ...
Cell cycle 8 (12), 1888-1895, 2009
4452009
Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition
MV Blagosklonny
Cell cycle 5 (18), 2087-2102, 2006
4312006
Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.
MV Blagosklonny, J Toretsky, S Bohen, L Neckers
Proceedings of the National Academy of Sciences 93 (16), 8379-8383, 1996
4291996
Growth stimulation leads to cellular senescence when the cell cycle is blocked
ZN Demidenko, MV Blagosklonny
Cell cycle 7 (21), 3355-3361, 2008
4072008
p53 inhibits hypoxia-inducible factor-stimulated transcription
MV Blagosklonny, WG An, LY Romanova, J Trepel, T Fojo, L Neckers
Journal of Biological Chemistry 273 (20), 11995-11998, 1998
4071998
The system can't perform the operation now. Try again later.
Articles 1–20